As of June 4, 2025, Thermo Fisher Scientific Inc (TMO) reports a EV/EBITDA of 14.74.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Thermo Fisher Scientific Inc's EV/EBITDA to Peers
To better understand Thermo Fisher Scientific Inc's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Thermo Fisher Scientific Inc (TMO) | 14.74 |
| Reflect Scientific Inc (RSCF) | 148.90 |
| Repligen Corp (RGEN) | 110.13 |
| International Isotopes Inc (INIS) | 47.92 |
| Qiagen NV (QGEN) | 34.60 |
| Bio-Techne Corp (TECH) | 27.94 |
Compared to its competitors, Thermo Fisher Scientific Inc's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.